SM
LONA

SG3 Management’s LeonaBio Inc LONA Stock Holding History

SG3 Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,600
Closed -$628K – 298
2022
Q2 		$628K Buy
20,600
+2,620
+15% +$240K 0.07% 183
2022
Q1 		$2.43M Buy
17,980
+10,860
+153% +$1.15M 0.07% 262
2021
Q4 		$928K Buy
+7,120
New +$900K 0.02% 500

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG3 Management's LONA Position: Q2 2022 in Review

SG3 Management sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 2,300 shares — an estimated $211K sold.

SG3 Management first reported a position in LONA in Q4 2021 and held it in 2 quarters. The position peaked at $586K in Q4 2021. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • SG3 Management reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 2,300 LeonaBio Inc shares in Q2 2022, an estimated $211K.
  • SG3 Management first reported a position in LeonaBio Inc in Q4 2021 and held it in 2 quarters.
  • SG3 Management's LeonaBio Inc position peaked at $586K in Q4 2021.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.